Burkitt Leukemia — Trials

Burkitt Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01842672	Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia(MITCL)	completed	Phase 1 / Phase 2	41	New York Medical CollegeOTHER	1	Oct 25, 2022	clinicaltrials

Data updated 22 days agoSource updated Oct 25, 2022source: clinicaltrials